Vasectomy

Research Presented at AUA 2024 Indicates Vasectomies Have Increased Since Dobbs Decision

Retrieved on: 
Friday, May 3, 2024

SAN ANTONIO, May 03, 2024 (GLOBE NEWSWIRE) -- Abstracts presented at the American Urological Association's Annual Meeting show increased vasectomy consults and procedures since the Dobbs decision in 2022.

Key Points: 
  • SAN ANTONIO, May 03, 2024 (GLOBE NEWSWIRE) -- Abstracts presented at the American Urological Association's Annual Meeting show increased vasectomy consults and procedures since the Dobbs decision in 2022.
  • Researchers will present policy and practice implications of the Dobbs decision study findings in San Antonio, Texas, from May 3 to 6.
  • Justin Dubin, MD, men’s health specialist at Memorial Healthcare System in South Florida, moderated a virtual press session with the abstract authors, providing key insights into their research.
  • “In this panel, you will learn about the impact the overturning of Roe vs. Wade had on the male partner and the role of vasectomy in men and potentially couples.”
    The following abstracts are covered in the moderated panel:

Signati™ Medical Enrolls First Patient in Groundbreaking Sealed Vasectomy Procedure Trial

Retrieved on: 
Tuesday, April 9, 2024

This significant reduction in procedure time holds immense promise for improving patient experience and potentially increasing vasectomy rates.

Key Points: 
  • This significant reduction in procedure time holds immense promise for improving patient experience and potentially increasing vasectomy rates.
  • Principal Investigator Dr. Matthew Mutter of LSU Medical Center commented on the first patient enrollment: "The Signati Separo™ worked flawlessly.
  • The Sealed Vasectomy Procedure (SVP)™ represents the first major advancement in vasectomy technology in over 40 years.
  • The SVP is a minimally invasive, procedure that offers several potential benefits over traditional vasectomy techniques, including:
    The IDE trial is a prospective study designed to evaluate the safety and efficacy of the Signati Separo™ for vasectomy.

Los Angeles Vasectomy and Vasectomy Reversal Specialist, Dr. Justin Houman, is Appointed Assistant Professor at Cedars-Sinai Medical Center

Retrieved on: 
Tuesday, January 23, 2024

LOS ANGELES, Jan. 23, 2024 /PRNewswire-PRWeb/ -- As an esteemed assistant professor in urology at Cedars-Sinai Medical Center, Dr. Justin Houman will continue enhancing the quality of life for men by improving their sexual, reproductive and hormonal health. Dr. Houman provides his patients with the latest and most effective treatments available, with extensive expertise in vasectomy, vasectomy reversal, infertility, testosterone, Peyronie's disease, erectile dysfunction and urology. Also, as a top minimally invasive microscopic surgeon, Dr. Houman delivers skill and expertise in microsurgical varicocelectomies, vasectomy reversals, sperm retrievals, penile implants and male incontinence. His vast knowledge and experience in urology have earned him recognition as a leading authority in men's health. Dr. Houman's appointment at Cedars-Sinai Medical Center is a testament to his exceptional skills, dedication and unwavering commitment to patient care. As an assistant professor, Dr. Houman will continue to contribute to the advancement of urological research and education for his patients and students.

Key Points: 
  • Board-certified and fellowship-trained urologist, Dr. Justin Houman, is a top men's health specialist and leading urological surgeon in the Los Angeles area.
  • LOS ANGELES, Jan. 23, 2024 /PRNewswire-PRWeb/ -- As an esteemed assistant professor in urology at Cedars-Sinai Medical Center, Dr. Justin Houman will continue enhancing the quality of life for men by improving their sexual, reproductive and hormonal health.
  • Dr. Houman provides his patients with the latest and most effective treatments available, with extensive expertise in vasectomy, vasectomy reversal , infertility, testosterone, Peyronie's disease, erectile dysfunction and urology.
  • Dr. Houman's appointment at Cedars-Sinai Medical Center is a testament to his exceptional skills, dedication and unwavering commitment to patient care.

Signati™ Medical, Inc. Receives FDA Approval for IDE Study

Retrieved on: 
Wednesday, December 20, 2023

Providence, RI, Dec. 20, 2023 (GLOBE NEWSWIRE) -- The FDA has officially approved Signati™ Medical’s Investigational Device Exemption (IDE) study!

Key Points: 
  • Providence, RI, Dec. 20, 2023 (GLOBE NEWSWIRE) -- The FDA has officially approved Signati™ Medical’s Investigational Device Exemption (IDE) study!
  • This comes on the company’s 5 year anniversary.
  • Louisiana State University Medical Center has agreed to conduct the study which should start in January 2024.
  • Signati’s™ device will be the only surgical device on the market to perform a Sealed Vasectomy Procedure (SVP)™.

YourChoice Therapeutics begins first-in-human trial for male birth control pill

Retrieved on: 
Wednesday, December 13, 2023

YourChoice Therapeutics, Inc., a pioneer of hormone-free family planning products, began dosing male volunteers in a phase one clinical study of YCT-529, a drug candidate designed to offer the first hormone-free male birth control pill.

Key Points: 
  • YourChoice Therapeutics, Inc., a pioneer of hormone-free family planning products, began dosing male volunteers in a phase one clinical study of YCT-529, a drug candidate designed to offer the first hormone-free male birth control pill.
  • While a male birth control pill has been a vision for decades, current drug candidates in clinical development use hormonal agents that suppress testosterone to prevent sperm production.
  • We thank our investors and the male volunteers who have stepped forward to be a part of this mission.”
    The Male Contraceptive Initiative has contributed generous funding to the development of the first hormone-free male birth control pill since its inception.
  • The first human study for a hormone-free male birth control pill is a long-awaited milestone and a landmark achievement in the quest for reproductive autonomy.

Minimally Invasive Vasectomy Procedures Drive Global Market's Growth to New Heights by 2028 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, September 12, 2023

The Global Vasectomy Market is on track to achieve remarkable growth, with forecasts indicating a substantial increase from USD 19.31 billion in 2023 to approximately USD 27.97 billion by 2028.

Key Points: 
  • The Global Vasectomy Market is on track to achieve remarkable growth, with forecasts indicating a substantial increase from USD 19.31 billion in 2023 to approximately USD 27.97 billion by 2028.
  • This upward trajectory corresponds to a robust Compound Annual Growth Rate (CAGR) of 7.68%, as revealed by an extensive industry analysis.
  • Vasectomy, a widely recognized and efficient male sterilization surgical procedure, involves the surgical interruption of the vas deferens to prevent sperm transport.
  • Noteworthy investments in research and development efforts, paired with technological innovations, are catalyzing the growth potential of the vasectomy market.

September is Sexual Health Month

Retrieved on: 
Thursday, September 7, 2023

One issue with sexual health is that it is often not talked about because it can be considered 'embarrassing'.

Key Points: 
  • One issue with sexual health is that it is often not talked about because it can be considered 'embarrassing'.
  • But having these conversations are vital for your overall health and wellness.
  • Below is a list of common misconceptions that AUA urologists have encountered across in their practices.
  • What else can you do to support your sexual health?

His Choice No Cut Vasectomy: The Newest No Scalpel Vasectomy Procedure

Retrieved on: 
Friday, September 1, 2023

His Choice vasectomy is a no needle, no scalpel vasectomy, single skin opening vasectomy procedure that can can be performed in an office setting in less than 15 minutes.

Key Points: 
  • His Choice vasectomy is a no needle, no scalpel vasectomy, single skin opening vasectomy procedure that can can be performed in an office setting in less than 15 minutes.
  • His Choice No Cut Vasectomy is the newest form of minimally invasive vasectomy.
  • His Choice vasectomy is a no needle, no scalpel vasectomy, single skin opening vasectomy procedure that can be performed in an office setting in less than 15 minutes.
  • His Choice vasectomy is the newest no scalpel vasectomy with a low risk of side-effects and a low risk of failure.

White men have controlled women’s reproductive rights throughout American history – the post-Dobbs era is no different

Retrieved on: 
Friday, September 1, 2023

Candidates sparred over the idea of a federal abortion ban during the Aug. 23, 2023, Republican presidential debate.

Key Points: 
  • Candidates sparred over the idea of a federal abortion ban during the Aug. 23, 2023, Republican presidential debate.
  • And abortion is likely to figure prominently in the November 2023 contest for a seat on the Pennsylvania Supreme Court.
  • White men controlled people’s reproductive rights during the 20th century, too, with the American eugenics movement.
  • As a researcher who specializes in the history of race and racism in the U.S., I study historical issues related to race, gender and social justice.

Enslaved women forced to reproduce

    • With this shift, enslavers stepped up the forced breeding of enslaved women.
    • White men raped the Black women andgirls they enslaved, and then enslaved the children born from those rapes.
    • Because the Black midwives and enslaved women often were blamed for or suspected of using birth control and abortions to resist forced pregnancy and the enslavement of their offspring, enslavers turned increasingly away from midwives and to white male doctors to figure out why nearly half of enslaved infants were stillborn or died within their first year of life and why so many enslaved women were infertile.
    • The forced breeding of these enslaved women was linked to the profitability of southern economies.

Eugenics and control over women’s bodies

    • Thirty-two states, between 1907 and 1937, enacted forced sterilization mandates to prevent births by people eugenicists considered socially inadequate.
    • For example, in North Carolina, which had the country’s third-highest sterilization rate, far more women than men were forcibly sterilized.
    • Between 1930 and 1970, close to 33% of the women in Puerto Rico, a U.S. territory, were forcibly sterilized.
    • In California, between 1997 and 2003, 1,400 female inmates, mostly Black, were forcibly sterilized.

The post-Dobbs era

    • The Census Bureau projects that in the 2040s, non-Hispanic white people will no longer make up a majority of the U.S. population.
    • Black women represent 39% of the country’s abortion patients, but many live in communities that have limited access to family planning clinics.
    • As a result, Black women - who experience higher maternal complications and mortality rates - will be forced to give birth to more babies.
    • This is another period in the country in which the reproductive health decisions made by mostly white men will harm Black women.

Global Condom Market Outlook & Forecast 2023-2028: Demographics and Demand Insights - Female Condoms on the Rise, APAC Leads the Way - ResearchAndMarkets.com

Retrieved on: 
Wednesday, August 23, 2023

Female condoms account for less share of the global condom market, and there is a huge opportunity for growth in the global female condom market.

Key Points: 
  • Female condoms account for less share of the global condom market, and there is a huge opportunity for growth in the global female condom market.
  • APAC held the most substantial global condom market share in 2022, accounting for over 37% in revenue.
  • The high penetration of condoms in countries such as Japan and China helped APAC contribute significantly to both value and volume of the global market.
  • The global condom market is characterized by high demand for male and female condoms.